Heres a summary of the weight loss trajectory across both medications: Weeks 1 to 4: 1 to 3% body weight loss (adjustment phase) Weeks 5 to 12: 5 to 8% (dose escalation, weight loss accelerating) Weeks 13 to 24: 10 to 17% (fastest weight loss period) Weeks 24 to 72: 17 to 22.5% (weight loss slowing, maintenance phase) Plateaus and weight fluctuations One of the most common concerns people have, especially from weeks 8 to 16, is that weight loss stalls
The first critical step is to not panic most accidental double doses can be managed effectively with appropriate monitoring and supportive care
Bram Brouwers, Ph.D., and Meri Kay Scott, Ph.D., for trial design advice
That NAION is so infrequent is a good thing for us, but a bad thing for researchers trying to figure out if semaglutide increases the risk of developing it
Currently, semaglutide, also known as Wegovy, is in short supply due to "unprecedented demand" after its approval